Historical Archive

Novartis, the revolt of the shareholders against the board

(basic fr.) Hard times also in Switzerland. The Novartis board risks not being confirmed for having granted the president an overly generous bonus. The attack was launched by the Ethos foundation, which brings together institutional investors, and which has sustainable development as its objective. But most of all «recommend» pension funds. The director of Ethos, Dominique Biedermann, told newspapers that the president of the pharmaceutical multinational Daniel Vasella (right photo«he earns millions of francs a month and it seems a bit much». Vasella was paid 13.5 million Swiss francs in 2011, while Novartis' profits fell by 7%. Ethos urged Novartis shareholders not to reappoint board members William Brody and Srikant Datar, members of the compensation committee.

3 February 2012 – Corriere della Sera – pag. 35

Ethos s'attaque à la pair du président de Novartis     

jeudi 2 fevrier

ZURICH, Feb 2 (Reuters) - The Ethos foundation believes that the action naires of the Novartis pharmaceutic group will need to vote for the election of the members of the administrative council responsible for the attribution of primes to the president, Daniel Vasella.

"Gagner un million de francs suisses par mois, c'est trop", a déclaré the director of the Fondation Ethos, Dominique Biedermann, à des journalistes à Zurich.

Daniel Vasella reçu 13,5 million de francs suisses (11,2 million d'euros) in 2011, contre 12 million de francs l'année précédente, alors que le bénéfice de Novartis a baissé de 7%.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco